AKT1 and COVID-19: Pelzl et al. found that incubation with sera or IgG increased the generation of procoagulant platelets from COVID-19 patients and that this is mediated by IgG antibodies through the PI3K/AKT signaling pathway in an FcγRIIA-dependent manner [45].